406MO Sequencing paired tumor DNA and white blood cells (WBCs) increases sensitivity to track plasma circulating tumor DNA (ctDNA) for detecting minimal residual disease (MRD) in localized colon cancer (CC)

Autor:	A. Ferrer-Martínez, J.A. Carbonell-Asins, S. Moragón, Susana Roselló, Alejandro Espí, P. Rentero-Garrido, S. Zuñiga, Valentina Gambardella, A. Peña, N. Tarazona, Pasquale Lombardi, Andrés Cervantes, M. Ponce, Desamparados Roda, R. Tébar-Martínez, Monica Huerta, C. Alfaro-Cervello, D. Moro, C. Martínez-Ciarpaglini, J. Martín-Arana
Rok vydání:	2020
Předmět:	business.industry Colorectal cancer Hematology medicine.disease Minimal residual disease White (mutation) chemistry.chemical_compound Oncology chemistry Circulating tumor DNA Cancer research Medicine Sensitivity (control systems) business DNA
Zdroj:	Annals of Oncology. 31:S413-S414
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.08.517
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6ffeef7b314b556ed363cf2ea0599a6a https://doi.org/10.1016/j.annonc.2020.08.517 Zobrazit plný text záznamu